Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 6—June 2026

Synopsis

Outcomes of Hospitalized and Critically Ill Adults with Murine Typhus, Galveston, Texas, USA, 2019–2023

Matthew PickichComments to Author , Puneet Singh, Efstathia Polychronopoulou, Shawn P. Nishi, Lucas S. Blanton, and Alexander G. Duarte
Author affiliation: University of Texas Medical Branch, Galveston, Texas, USA

Main Article

Table 3

Laboratory values and radiographic findings of hospitalized adults with murine typhus, Galveston, Texas, USA, 2019–2023*

Test No. patients tested Non-ICU patients, n = 86 ICU patients, n = 33 Reference range p value
Alanine aminotransferase, U/L 112 111 (68–166) 95 (70–140) 5–35 0.34
Aspartate aminotransferase, U/L 118 143 (96–216) 153 (96–224) 13–40 0.71
Alkaline phosphatase, U/L 118 140 (84–216) 137 (90–207) 34–122 0.68
Creatinine, mg/dL 119 0.87 (0.69–1.04) 0.99 (0.81–2.21) 0.5–1.4 0.06
Leukocytes, × 103 cells/μL 119 7.8 (5.9–10.6) 10.8 (7.1–15.5) 4.3–11.1 0.005
Hemoglobin, g/dL 119 12.9 (11.7–14.3) 12.2 (11.3–13.6) 12.2–16.4 0.26
Platelets, × 103/μL 119 117 (79–162) 97 (45–151) 135–351 0.01
Neutrophils, × 103 cells/μL 117 6.0 (4.3–8.0) 8.3 (6.1–11.9) 1.99–6.95 0.002
Lymphocytes, × 103 cells/μL 117 1.2 (0.84–1.96) 0.85 (0.56–1.51) 1.09–3.23 L 0.04
Monocytes, × 103 cells/μL 117 0.36 (0.26–0.56) 0.38 (0.29–0.72) 0.36–1.02 0.40
Serum albumin, g/dL 118 3.5 (3.2–3.8) 3.2 (2.9–3. 5) 3.5–5 L 0.024
Serum sodium, mmol/L 119 131 (129–134) 128 (137–130) 135–145 0.022
Procalcitonin, ng/mL
44
1.1 (0.4–2.5)
3.8 (0.9–7.4)
<0.07
0.045
Chest radiograph findings, no. (%) 0.10
Clear lung fields 52 (64.2) 14 (43.8)
Opacities/infiltrates 27 (33.3) 15 (46.8)
Effusion 2 (2.5) 3 (9.4)

*Values are median (interquartile range) except as indicated. ICU, intensive care unit.

Main Article

Page created: April 29, 2026
Page updated: June 01, 2026
Page reviewed: June 01, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external